Skip to main content
. 2018 Oct 1;2018:6460379. doi: 10.1155/2018/6460379

Table 2.

Study characteristics.

Author (year) Research type Population Study length (years) C MD O DM OSA
Total Control (asthma-only) Comorbid condition
Kendzerska et al. [8] Retrospective cohort 10 M
Baarnes et al. [9] Retrospective cohort 57,053 1,845 662 4 M
Yamauchi et al. [10] Retrospective cohort 30,405 19,865 6,279 3 M and ER
Harada et al. [11] Retrospective 650 474 176 12 M
Becerra et al. [12] Inpatient sample study 179, 789 136,118 8,189 3 LOS
Vuillermin et al. [13] Cross-sectional analysis 615 410 205 1 ER
Ahmedani et al. [14] Prospective follow-up study 568 N/A 187 1 ER
Wiesenthal et al. [15] Prospective follow-up study 460 227 233 3 ER
Hsiao et al. [16] Retrospective cohort 17,725 766 3,545 13 ER

Description of results from each selected article regarding the significant differences in hospital/emergency room (ER) visits, mortality (M), and hospital length of stay (LOS) in patient due to the chronic disease comorbidity compared to the asthma-only control. C,  COPD/asthma comorbidity; MD,  mental disorder/asthma comorbidity; O,  obesity/asthma comorbidity; D ,  diabetes mellitus/asthma comorbidity; OSA ,  obstructive sleep apnea. This paper utilized a population health administrative data for all individuals living in Ontario, Canada (population of approximately 13 million in 2010) that are over the age of 35. ∗∗No articles were found that discussed the clinical impacts of either hypertension-asthma, myocardial ischemia-asthma, or rhinitis/sinusitis-asthma comorbidity.